Market Alert: Trump Revives Trade War Playbook with Tariff Threats
Anagenics Limited (ASX: AN1) reported a notable improvement in its third-quarter FY2025 operating performance, posting a net profit before tax of AU$138,000. This positive outcome stems from strategic restructuring efforts despite revenue disruptions due to a temporary warehousing transition in January, which led to 2.5 weeks of lost operations. Operating cash outflows improved significantly to AU$0.4 million, down from AU$0.9 million in the first quarter. The adjusted operating cash flow would have turned positive if not for payments related to legacy liabilities. The company asserts it has enough capital to meet operational needs for the next two quarters without requiring new equity funding. Anagenics continues to pursue growth through the global sale of proprietary and licensed anti-aging products, spearheaded by its subsidiary, BLC Cosmetics Pty Ltd. This momentum reflects the company's strategic focus on profitability and sustainable shareholder value through clinically validated wellness solutions
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Jul 11, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
